Clinical Trial Update: Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for VT3989 in adults with metastatic solid tumors, including mesothelioma and non-small cell lung cancer, currently recruiting in Phase 1/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mesothelioma
• Non-small Cell Lung Cancer

Drugs mentioned

• VT3989

Snippet

Sponsor: Vivace Therapeutics, Inc | Conditions: Solid Tumor, Adult, Mesothelioma | Phase 1, Phase 2 | Status: RECRUITING